13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001274403
Total reported value
$1.1B
$1.1B
9 檔
20.5%
The Q4 2024 SEC filing reveals that ARCH Venture Management, LLC held a total portfolio value of $1.1B, covering 9 public equity positions.
During Q4 2024, ARCH Venture Management, LLC performed routine portfolio adjustments (0 new buys, 1 additions, 1 trims, and 0 full exits), keeping overall allocation balanced.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BEAM | Beam Therapeutics Inc | Stock-Other | 48.91% | -1.82% | -6.09% | |
| 2 | RAPP | Rapport Therapeutics Inc | Stock-Other | 28.73% | -3.11% | — | |
| 3 | ERAS | Erasca Inc | Stock-Other | 12.05% | -5.14% | — | |
| 4 | ✓ | Verve Therapeutics Inc | Stock-Other | 4.92% | — | — | |
| 5 | GOSS | Gossamer Bio Inc | Stock-Other | 3.17% | -0.27% | — | |
| 6 | ✓ | Stock-Other | 1.07% | — | — | ||
| 7 | QTTB | Q32 Bio Inc | Stock-Other | 0.48% | -0.30% | EXIT | |
| 8 | UNBX | Unity Biotechnology Inc | Stock-Other | 0.43% | — | — | |
| 9 | FENG | Phoenix New Media Limited | Stock-Other | 0.24% | — | +550.39% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BEAM | Beam Therapeutics Inc | +3.5% | -6.09% | Trim |
| 2 | ✓ | Verve Therapeutics Inc | +1.2% | — | Unchanged |
| 3 | ERAS | Erasca Inc | +0.5% | — | Unchanged |
| 4 | ✓ | +0.3% | — | Unchanged | |
| 5 | FENG | Phoenix New Media Limited | +0.2% | +550.39% | Add |
| 6 | GOSS | Gossamer Bio Inc | +0.1% | — | Unchanged |
| 7 | UNBX | Unity Biotechnology Inc | -0.1% | — | Unchanged |
| 8 | RAPP | Rapport Therapeutics Inc | -0.6% | — | Unchanged |
| 9 | QTTB | Q32 Bio Inc | -5% | — | Unchanged |
According to official SEC Form 13F filings, ARCH Venture Management, LLC reported a total U.S. public equity portfolio value of $1.1B across 9 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BEAM, RAPP, ERAS) accounted for 20.5% of total reported equity market value during Q4 2024.
Top Position Liquidated / Trimmed
BEAM
前期市值: $118.4M
During Q4 2024, ARCH Venture Management, LLC's top holdings by market value included BEAM (48.9%)、RAPP (28.7%)、ERAS (12.1%). The largest single position, BEAM, represented 48.9% of total portfolio value.
In Q4 2024, ARCH Venture Management, LLC made 2 total portfolio adjustments, initiating 0 new buys, adding to 1 positions, trimming 1 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.